---
ver: rpa2
title: Implementation of AI in Precision Medicine
arxiv_id: '2510.14194'
source_url: https://arxiv.org/abs/2510.14194
tags:
- medicine
- https
- data
- artificial
- clinical
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This scoping review identified key barriers and enablers to AI
  implementation in precision medicine across data quality, clinical reliability,
  workflow integration, and governance. The analysis revealed that AI applications
  remain predominantly at the proof-of-concept stage, with limited real-world clinical
  adoption.
---

# Implementation of AI in Precision Medicine

## Quick Facts
- arXiv ID: 2510.14194
- Source URL: https://arxiv.org/abs/2510.14194
- Reference count: 11
- AI applications remain predominantly at proof-of-concept stage with limited real-world clinical adoption

## Executive Summary
This scoping review examines barriers and enablers to AI implementation in precision medicine across four dimensions: data quality, clinical reliability, workflow integration, and governance. The analysis reveals that AI applications remain predominantly at proof-of-concept stage with limited real-world clinical adoption. Major challenges include fragmented and non-representative datasets, black-box model opacity hindering clinician trust, poor interoperability with existing systems, and ethical concerns around algorithmic bias and data privacy. The review emphasizes that successful AI implementation requires coordinated investments in data standardization, explainable AI frameworks, clinician-AI collaboration, and adaptive governance structures that ensure transparency and accountability throughout the AI lifecycle.

## Method Summary
This scoping review conducted a Scopus database search using the query: ("Precision Medicine" OR "Personalized Medicine") AND ("AI" OR "Machine Learning" OR "Artificial Intelligence") AND ("Implementation" OR variants), yielding 698 initial articles. After screening for relevance and applying inclusion criteria (focus on implementation, AI/ML, and precision medicine), 108 articles were included. The review analyzed implementation-related insights and categorized them across four dimensions: data quality, clinical reliability, workflow integration, and governance, along with specialty areas.

## Key Results
- AI applications remain predominantly at proof-of-concept stage with limited real-world clinical adoption
- Major barriers include fragmented/non-representative datasets, black-box model opacity, poor interoperability, and ethical concerns
- Successful implementation requires coordinated investments in data standardization, explainable AI, clinician-AI collaboration, and adaptive governance

## Why This Works (Mechanism)

### Mechanism 1
- **Claim:** Standardized, multi-institutional data curation is a conditional prerequisite for model generalizability in precision medicine.
- **Mechanism:** By normalizing heterogeneous inputs (genomic, clinical, lifestyle) into common ontologies and metadata schemas, the system reduces variance between training environments and deployment sites, allowing models to perform consistently across different patient populations.
- **Core assumption:** Assumes that technical standardization can effectively resolve biological and procedural heterogeneity inherent in diverse healthcare settings.
- **Evidence anchors:**
  - [abstract]: Identifies "fragmented and non-representative datasets" as a major barrier; emphasizes "data standardization" as a requirement.
  - [section 3.3]: Notes that "model optimization is secondary to data quality" and proposes "standardized data curation pipelines with common ontologies."
  - [corpus]: *Holistic Artificial Intelligence in Medicine* supports the difficulty of fusing multimodal data without robust frameworks.
- **Break condition:** If training data remains single-institutional or lacks demographic diversity despite standardization, the mechanism fails to prevent site-specific bias.

### Mechanism 2
- **Claim:** Explainable AI (XAI) frameworks may bridge the "translational gap" by aligning computational outputs with clinical reasoning.
- **Mechanism:** XAI provides interpretable reasoning paths rather than raw probabilities, allowing clinicians to validate AI predictions against their own expertise. This transparency is posited to restore "epistemic authority" to the clinician, reducing resistance to adoption.
- **Core assumption:** Assumes that clinicians will trust a system if the logic is visible, and that visualized logic aligns with medical heuristics.
- **Evidence anchors:**
  - [section 3.4]: Describes "black-box" opacity as hindering trust; suggests XAI allows clinicians to understand "why models produce specific predictions."
  - [section 3.5]: Proposes a "humanâ€“AI loop" where AI informs but does not replace human decision-making.
  - [corpus]: *Artificial Intelligence Should Genuinely Support Clinical Reasoning* reinforces the need to bridge the translational gap via reasoning support.
- **Break condition:** If the explanation provided by XAI is too complex or contradicts established clinical heuristics, trust is unlikely to form.

### Mechanism 3
- **Claim:** Adaptive governance structures function as a feedback loop to maintain safety and equity over time.
- **Mechanism:** Continuous monitoring and "dynamic consent" models allow the system to detect "model drift" (performance degradation over time) or emerging bias. This triggers necessary updates or restrictions, ensuring the system remains compliant with ethical standards as the patient population changes.
- **Core assumption:** Assumes that regulatory bodies and hospitals can implement the necessary infrastructure to audit models in real-time or near-real-time.
- **Evidence anchors:**
  - [section 4]: Describes an ecosystem where "real-world performance data... reveal gaps... feeding back into data governance."
  - [section 3.6]: Recommends "algorithmic auditing" and "dynamic consent models" to handle data repurposing and drift.
  - [corpus]: *Transparent AI* supports the necessity of transparency for responsible implementation.
- **Break condition:** If governance is static (e.g., model is deployed and forgotten), the system fails to adapt to new ethical challenges or data distribution shifts.

## Foundational Learning

- **Concept: Multimodal Data Interoperability**
  - **Why needed here:** Precision medicine relies on fusing genomic, imaging, and clinical data. The paper highlights that these datasets are currently fragmented.
  - **Quick check question:** Can you map how a genomic marker and a radiology image are linked to a single patient ID in your current system?

- **Concept: Epistemic Authority & Human-in-the-Loop**
  - **Why needed here:** The paper notes that AI often fails because it disrupts clinical hierarchy and decision-making confidence.
  - **Quick check question:** Does your system design position the AI as an "oracle" (giving answers) or a "collaborator" (providing evidence for the clinician to judge)?

- **Concept: External Validation & Temporal Drift**
  - **Why needed here:** High accuracy in a lab setting does not guarantee clinical reliability. The paper emphasizes validation across different institutions and timeframes.
  - **Quick check question:** Has your model been tested on data from a hospital it was not trained on, or on data from 2024 if trained on 2020 data?

## Architecture Onboarding

- **Component map:**
  - Input Layer: Multimodal Data Sources (EHR, Genomics, Wearables)
  - Preprocessing Layer: Standardization/Curation Pipelines (Ontologies, De-identification)
  - Core Layer: AI Model + Explainability (XAI) Interface
  - Integration Layer: Clinical Decision Support System (CDSS) API
  - Control Layer: Governance & Auditing Module (Bias monitoring, Drift detection)

- **Critical path:**
  1. **Data Audit:** Assess representativeness and quality of datasets (Section 3.3)
  2. **Validation Protocol:** Establish external/temporal validation standards before deployment (Section 3.4)
  3. **Workflow Integration:** Design the "Human-AI loop" interface to support, not replace, clinician decisions (Section 3.5)

- **Design tradeoffs:**
  - **Accuracy vs. Generalizability:** Optimizing for specific institutional data (high accuracy) often reduces performance on diverse populations (low generalizability)
  - **Opacity vs. Performance:** Complex deep learning models often offer higher accuracy but lack the explainability required for trust (Black box problem)
  - **Automation vs. Control:** Fully automated systems may be efficient but face high regulatory hurdles; assisted decision systems are safer but slower

- **Failure signatures:**
  - **Model Drift:** Sudden drop in prediction accuracy as patient demographics or clinical practices change over time (Section 3.4)
  - **Algorithmic Bias:** Systematic errors in outcomes for specific demographic groups due to non-representative training data (Section 3.6)
  - **Workflow Friction:** Clinicians ignoring AI outputs due to lack of interoperability or trust (Section 3.5)

- **First 3 experiments:**
  1. **Data Representativeness Audit:** Quantify the demographic and institutional diversity of the training set against the target deployment population
  2. **XAI Usability Test:** Deploy the explanation interface to a small clinician group to measure if "reasoning paths" increase trust or cause confusion
  3. **Shadow Mode Deployment:** Run the AI in parallel with clinical workflows without exposing results, to measure potential workflow disruption and performance gap (temporal validation)

## Open Questions the Paper Calls Out
None

## Limitations
- Scoping review framework constrains depth of analysis for individual mechanisms, providing breadth but limited causal evidence
- Thematic synthesis approach relies heavily on qualitative interpretation of implementation literature, introducing potential subjectivity
- Review captures state of AI implementation through 2024, potentially missing rapid technological developments since publication

## Confidence

- **High Confidence:** Identification of data fragmentation and standardization challenges as primary barriers (supported by multiple papers including *Holistic Artificial Intelligence in Medicine* and *Transparent AI*)
- **Medium Confidence:** Proposed mechanisms linking XAI to trust and governance to safety (theoretically sound but implementation-dependent)
- **Low Confidence:** Specific claims about relative importance of different barriers across specialties (scoping review methodology doesn't support quantitative prioritization)

## Next Checks

1. **Data Representativeness Audit:** Conduct systematic audit of training datasets across multiple institutions to quantify demographic and institutional diversity gaps against target populations
2. **XAI Usability Validation:** Deploy explanation interfaces with representative clinician sample to empirically measure trust changes and identify where explanations either build or undermine confidence
3. **Governance Infrastructure Assessment:** Evaluate current hospital capabilities for real-time model monitoring and auditing to determine feasibility of proposed adaptive governance structures